Rash & Diarrhea Prophylaxis With Capivasertib

NCT07426822 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Metastatic HR+/HER2- Breast Cancer

Interventions

DRUG: Capivasertib
DRUG: Loperamide
DRUG: Fulvestrant
DRUG: Ceterizine

Sponsor

Maryam Lustberg

Collaborators

[object Object]